Related Experiment Video
Updated: May 23, 2026
10:02
piggyBac Transposon System Modification of Primary Human T Cells
Published on: November 5, 2012
Chimeric piggyBac transposases for genomic targeting in human cells
Jesse B Owens1, Johann Urschitz, Ilko Stoytchev
1Institute for Biogenesis Research, Department of Anatomy, Biochemistry, and Physiology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96822, USA.
Nucleic Acids Research
|April 12, 2012
Summary
Researchers engineered the piggyBac (PB) transposase to precisely insert genes using Gal4-PB fusion proteins. This targeted gene delivery system enhances control for genetic engineering and gene therapy applications.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Gene insertion using viral or transposon vectors can be semi-random, risking gene disruption.
- Precise control over transgene insertion sites is crucial for therapeutic applications.
- The piggyBac (PB) transposase is an efficient gene transfer system amenable to modification.
Purpose of the Study:
- To design and validate chimeric PB proteins fused to the Gal4 DNA-binding domain for targeted gene insertion.
- To assess the ability of Gal4-PB fusion proteins to direct transgenes to specific genomic locations.
Main Methods:
- Constructed chimeric Gal4-PB fusion proteins (N- and C-terminal).
- Utilized plasmids with Upstream Activating Sequence (UAS) Gal4 recognition sites.
- Introduced UAS sites into the genome using the Sleeping Beauty transposon.
- Performed genome-wide integration analysis.
Main Results:
- Chimeric Gal4-PB transposase preferentially targeted UAS sites on plasmids in human cells.
- Both N- and C-terminal Gal4-PB fusion proteins, unlike native PB, targeted transposition near introduced chromosomal UAS sites.
- Fusion constructs biased 24% of integrations near endogenous Gal4 recognition sequences.
Conclusions:
- Developed a powerful approach to enhance the PB system's targeting capabilities.
- Gal4-PB fusion proteins enable site-specific gene delivery, improving precision.
- This technology holds promise for advancing genetic engineering and gene therapy.
